Nuwellis (NUWE) Assets Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.78% |
| Dec 31, 2025 | -37.18% |
| Sep 30, 2025 | -24.34% |
| Jun 30, 2025 | -25.22% |
| Mar 31, 2025 | -35.50% |
| Dec 31, 2024 | -31.30% |
| Sep 30, 2024 | -41.78% |
| Jun 30, 2024 | -40.67% |
| Mar 31, 2024 | -41.67% |
| Dec 31, 2023 | -21.26% |
| Sep 30, 2023 | -21.60% |
| Jun 30, 2023 | 5.77% |
| Mar 31, 2023 | 22.52% |
| Dec 31, 2022 | 63.92% |
| Sep 30, 2022 | 34.46% |
| Jun 30, 2022 | 24.40% |
| Mar 31, 2022 | 19.33% |
| Dec 31, 2021 | 51.34% |
| Sep 30, 2021 | 42.47% |
| Jun 30, 2021 | 39.42% |
| Mar 31, 2021 | 32.55% |
| Dec 31, 2020 | 2.74% |
| Sep 30, 2020 | 36.43% |
| Jun 30, 2020 | 3.64% |
| Mar 31, 2020 | 8.70% |
| Dec 31, 2019 | -9.15% |
| Sep 30, 2019 | 4.63% |
| Jun 30, 2019 | -4.20% |
| Mar 31, 2019 | -4.75% |
| Dec 31, 2018 | -28.93% |
| Sep 30, 2018 | -26.23% |
| Jun 30, 2018 | -32.08% |
| Mar 31, 2018 | -28.11% |
| Dec 31, 2017 | -17.08% |
| Sep 30, 2017 | -37.24% |
| Jun 30, 2017 | -35.19% |
| Mar 31, 2017 | -45.71% |
| Dec 31, 2016 | -48.67% |
| Sep 30, 2016 | -52.25% |
| Jun 30, 2016 | -16.89% |
| Mar 31, 2016 | 14.25% |
| Dec 31, 2015 | 17.59% |
| Sep 30, 2015 | 16.43% |
| Jun 30, 2015 | 129.01% |
| Mar 31, 2015 | 98.00% |
| Dec 31, 2014 | 63.32% |